[go: up one dir, main page]

GB202305637D0 - Transposons, vectors and genetically engineered cells - Google Patents

Transposons, vectors and genetically engineered cells

Info

Publication number
GB202305637D0
GB202305637D0 GBGB2305637.7A GB202305637A GB202305637D0 GB 202305637 D0 GB202305637 D0 GB 202305637D0 GB 202305637 A GB202305637 A GB 202305637A GB 202305637 D0 GB202305637 D0 GB 202305637D0
Authority
GB
United Kingdom
Prior art keywords
transposons
vectors
genetically engineered
engineered cells
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2305637.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macomics Ltd
Original Assignee
Macomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macomics Ltd filed Critical Macomics Ltd
Priority to GBGB2305637.7A priority Critical patent/GB202305637D0/en
Publication of GB202305637D0 publication Critical patent/GB202305637D0/en
Priority to PCT/EP2024/060455 priority patent/WO2024218170A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB2305637.7A 2023-04-17 2023-04-17 Transposons, vectors and genetically engineered cells Ceased GB202305637D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2305637.7A GB202305637D0 (en) 2023-04-17 2023-04-17 Transposons, vectors and genetically engineered cells
PCT/EP2024/060455 WO2024218170A1 (en) 2023-04-17 2024-04-17 Transposons, vectors and genetically engineered cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2305637.7A GB202305637D0 (en) 2023-04-17 2023-04-17 Transposons, vectors and genetically engineered cells

Publications (1)

Publication Number Publication Date
GB202305637D0 true GB202305637D0 (en) 2023-05-31

Family

ID=86497247

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2305637.7A Ceased GB202305637D0 (en) 2023-04-17 2023-04-17 Transposons, vectors and genetically engineered cells

Country Status (2)

Country Link
GB (1) GB202305637D0 (en)
WO (1) WO2024218170A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010118360A1 (en) 2009-04-09 2010-10-14 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Production of proteins using transposon-based vectors
PL2951309T3 (en) 2013-02-01 2019-06-28 Selexis S.A. Enhanced transgene expression and processing
GB201705927D0 (en) 2017-04-12 2017-05-24 Oxford Genetics Ltd Vector
JP7407425B2 (en) * 2018-05-18 2024-01-04 ソルボンヌ・ユニヴェルシテ Molecular tools and methods for transgene integration and their transposition-dependent expression
US20220033845A1 (en) 2018-09-24 2022-02-03 Merck Sharp & Dohme Corp. Expression vectors for eukaryotic expression systems
US20220090142A1 (en) 2019-02-13 2022-03-24 Probiogen Ag Transposase with enhanced insertion site selection properties
IL301620B1 (en) 2019-04-08 2025-05-01 Dna Twopointo Inc Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias
WO2020210237A1 (en) * 2019-04-08 2020-10-15 Dna Twopointo Inc. Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois
WO2021072777A1 (en) * 2019-10-18 2021-04-22 Egenesis, Inc. Cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance
MX2023005549A (en) 2020-11-13 2023-07-18 Egenesis Inc CELLS, TISSUES, ORGANS AND ANIMALS THAT HAVE ONE OR MORE MODIFIED GENES TO ENHANCE SURVIVAL AND TOLERANCE TO XENOGRAFT.

Also Published As

Publication number Publication date
WO2024218170A1 (en) 2024-10-24

Similar Documents

Publication Publication Date Title
SG11202101994XA (en) Genetically engineered hematopoietic stem cells and uses thereof
EP4125948A4 (en) Mitochondria-enriched genetically engineered cells and uses thereof
IL277703A (en) T cell receptors and engineered cells expressing same
GB2598839B (en) Electrochemical cell stack
SG11202011392VA (en) Genetically engineered cell and application thereof
EP4089174A4 (en) Engineered immune cell and use thereof
SG11202111679XA (en) Engineered cells and uses thereof
IL287777A (en) Engineered t cells
IL290795A (en) Genetically engineered t cells having improved persistence in culture
HUE067666T2 (en) Battery cell, battery, and electrical apparatus
IL289353A (en) Cell for resisting transplant reaction and method
EP4383362A4 (en) Cathode material, battery using said cathode material, and method for charging battery
GB202305637D0 (en) Transposons, vectors and genetically engineered cells
GB202208605D0 (en) Engineered immune cells
SG10201907378QA (en) Genetically modified nk cells and uses thereof
GB202118201D0 (en) Engineered immune cell
EP4021465A4 (en) Engineered immune cells
SG10201909544YA (en) Genetically Modified T Cells And Uses Thereof
GB202214410D0 (en) genetically modified cells
EP3912219A4 (en) Improved z wrap separators, cells, systems, batteries, and related equipment and methods
IL320363A (en) Genetically engineered cells
EP3787083A4 (en) Composite, and electrochemical reaction cell stack
IL320650A (en) Genetically engineered cells having anti-nectin4 chimeric antigen receptors, and uses thereof
HK40085182A (en) Mitochondria-enriched genetically engineered cells and usesthereof
HK40098659A (en) Genetically engineered cells and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)